Inicio › Cáncer del colon y del recto › Virginia

Ensayos clínicos de Cáncer del colon y del recto en Virginia

76 estudios sobre Cáncer del colon y del recto buscan participantes en Virginia.

Ciudades en Virginia

Texto oficial del estudio (inglés)

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 2, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07085091

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Inova Schar Cancer Institute, Fairfax
Virginia Cancer Specialists, PC, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06324357

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

UVA Comprehensive Cancer Center, Charlottesville
Virginia Cancer Specialists, Fairfax

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07659795

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NEXT Oncology, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05482893

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Blue Ridge Cancer Care - Blacksburg /ID# 280115, Blacksburg

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07525206

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06820463

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Virginia Cancer Specialists, PC, Arlington
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg
Virginia Cancer Specialists, PC, Fairfax
y 12 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07222800

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Virginia Cancer Specialists, Arlington
Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax
Richmond VA Medical Center, Richmond
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06662786

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Virginia Cancer Specialists, Arlington
Richmond VA Medical Center, Richmond
VCU Massey Comprehensive Cancer Center, Richmond

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06750094

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 0295), Roanoke

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06428409

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Local Institution - 0278, Fairfax
Virginia Oncology Associates, Norfolk

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07221357

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

University of Virginia Cancer Center, Charlottesville
VCU Massey Comprehensive Cancer Center, Richmond

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT06102902

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Virginia Cancer Specialists, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06445062

A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

NEXT Virginia, Faifax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07693751

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Next Oncology Virginia Cancer Specialist, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07629960

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NEXT - Virginia, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07349537

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

NEXT Virginia, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT05786924

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Virginia Cancer Specialists, Fairfax

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT04585750

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

University of Virginia Medical Center, Charlottesville
Mary Washington Healthcare, Fredericksburg
Hematology Oncology Associates of Fredericksburg Admin, Fredericksburg
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT07284849

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Virginia Oncology Associates, Newport News
Blue Ridge Cancer Care - 300202915, Roanoke

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07549412

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NEXT Oncology, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06440005

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Charlottesville
Clinical Study Site, Fairfax

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT07228832

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Bon Secours Memorial Regional Medical Center, Mechanicsville
Bon Secours Saint Francis Medical Center, Midlothian
Bon Secours Saint Mary's Hospital, Richmond
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT05673148

The Vanguard Study: Testing a New Way to Screen for Cancer

Sentara Martha Jefferson Hospital, Charlottesville
Inova Schar Cancer Institute, Fairfax
Inova Fair Oaks Hospital, Fairfax
y 5 más

ReclutandoSe aceptan voluntarios sanos

Edades de 45 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT06995898

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Chesapeake Regional Medical Center, Chesapeake
Augusta Health Center for Cancer and Blood Disorders, Fishersville
Bon Secours Memorial Regional Medical Center, Mechanicsville
y 7 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT05334069

Family Communications After Genetic Testing

VCU Massey Comprehensive Cancer Center, Richmond
VCU Community Memorial Health Center, South Hill

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07143487

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

Inova Schar Cancer, Fairfax

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT06992258

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

NEXT Virginia, Fairfax

ReclutandoFase 1

Edades de 18 a 99 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06983743

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NEXT Virginia, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 ago 2026 · NCT07227168

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

NEXT Oncology, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 ago 2026 · NCT07321106

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Virginia Cancer Institute (VCI), Richmond
Virginia Commonwealth University, Richmond

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT06728072

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Virginia, Charlottesville

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05919264

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

University of Virginia Health, Charlottesville

Reclutando

Edades de 65 a 82 · Todos los sexos · Actualizado el 13 ago 2026 · NCT05612347

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

NEXT Virginia, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 ago 2026 · NCT07066657

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Virginia Cancer Specialists, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06330064

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #66, Charlottesville

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT05176483

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

NEXT Virginia, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT07397338

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NEXT Virginia, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT06270706

De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.